Foresite Capital Opportunity Management V, LLC Compass Therapeutics, Inc. Transaction History
Foresite Capital Opportunity Management V, LLC
- $33.3 Million
- Q3 2022
A detailed history of Foresite Capital Opportunity Management V, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Opportunity Management V, LLC holds 1,554,250 shares of CMPX stock, worth $4.62 Million. This represents 10.64% of its overall portfolio holdings.
Number of Shares
1,554,250
Previous 1,554,250
-0.0%
Holding current value
$4.62 Million
Previous $4.12 Million
13.96%
% of portfolio
10.64%
Previous 10.38%
Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
89Shares Held
93.2MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$66.4 Million0.88% of portfolio
-
Blackstone Inc New York, NY10MShares$29.8 Million0.07% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.57MShares$25.4 Million1.86% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$19.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.99MShares$17.8 Million0.02% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $301M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...